Hormel Foods and Celsius Holdings are set to report Q4 results, highlighting a sharp divergence between legacy protein producers and high-growth functional beverages. Investors are closely monitoring Hormel's margin recovery and Celsius's inventory stabilization following recent distribution shifts with PepsiCo.
Hormel Foods and Celsius Holdings are set to report Q4 results, highlighting a divergence in the consumer goods sector between defensive staples and high-velocity functional beverages. While Hormel navigates commodity volatility and brand revitalization, Celsius faces scrutiny over its distribution scaling and market share retention.
Hormel Foods has entered a definitive agreement to sell its commodity-focused whole-bird turkey business to Life-Science Innovations. The strategic divestiture aims to reduce exposure to seasonal volatility and pivot the company's turkey portfolio toward higher-margin, value-added products.